株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

OTC / DTC感染症診断市場:2020-2024年

OTC/DTC INFECTIOUS DISEASE DIAGNOSTICS Strategies and Trends. Forecasts by Application by Channel by Country. With Market Analysis, Executive Guides and Customization. 2020 to 2024

発行 Howe Sound Research 商品コード 913420
出版日 ページ情報 英文 369 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
OTC / DTC感染症診断市場:2020-2024年 OTC/DTC INFECTIOUS DISEASE DIAGNOSTICS Strategies and Trends. Forecasts by Application by Channel by Country. With Market Analysis, Executive Guides and Customization. 2020 to 2024
出版日: 2019年11月02日 ページ情報: 英文 369 Pages
概要

当レポートでは、世界のOTC (Over the Counter) / DTC (Direct to Consumer) 感染症診断市場を調査し、市場の定義、各病原体のガイド、および産業概要などを提供しており、市場成長への影響要因、近年の発展動向、主要企業、症候群・チャネル別の市場について分析しています。

第1章 イントロダクション・市場定義

第2章 感染症 - 病原体のガイド

  • HIV - ヒト免疫不全ウイルス (AIDS)
  • HBV - B型肝炎
  • HCV - C型肝炎
  • HPV - ヒトパピローマウィルス
  • インフルエンザ
  • CT/NG - クラミジア/淋病
  • UTI - 尿路感染症
  • GAS - 溶連菌感染症
  • RESP

第3章 産業概要

  • 市場参入企業
  • 臨床ラボ・市場セグメント
  • 産業構造

第4章 市場動向

  • 市場成長の促進要因
  • 市場成長の抑制要因
  • 診断技術の発達

第5章 OTC/DTC感染症検査の近年の発展

第6章 主な感染症検査企業のプロファイル

第7章 世界市場の規模

第8章 世界市場:症候群別

  • 呼吸器症候群
  • STD市場
  • UTI市場
  • HxV市場
  • その他市場

第9章 世界市場:チャネル別

  • OTC/DTC市場:チャネル別
  • OTC市場
  • DTC市場
  • HSG市場

第10章 付録

図表

Table of Tables

  • Table 1 Medicare Clinical Lab Expenditures Actual & Forecast 2014 to 2024 ($Billion)
  • Table 2 Classification of HIV Species
  • Table 3 HBV Tests - CMS Codes & Prices
  • Table 4 HCV Tests - CMS Codes & Prices
  • Table 5 HPV Clearance Rates
  • Table 6 HPV Tests - CMS Codes & Prices
  • Table 7 HPV Tests, Technology, Types
  • Table 8 Types of Influenza Tests
  • Table 9 Influenza Tests - CMS Codes & Prices
  • Table 10 FDA Cleared Molecular Assays for Influenza
  • Table 11 FDA Cleared NAAT CTGC Tests
  • Table 12 CTGC NAAT Target Sequences and Possible False Reactions
  • Table 13 CT/NG Tests - CMS Codes & Prices
  • Table 14 GAS Panel BioFire
  • Table 15 BioFire RESP Panel
  • Table 16 Market Players by Type
  • Table 17 Clinical Laboratory Departments and Segments
  • Table 18 Laboratory Management Focus - Different Approaches
  • Table 19 Key Segmentation Variables Going Forward
  • Table 20 Possible Market Segments of OTC/DTC Market
  • Table 21 Five Factors Driving Growth
  • Table 22 Four Factors Limiting Growth
  • Table 23 Self vs. Send TAT
  • Table 24 OTC/DTC ID Global Market by Country/Region
  • Table 25 OTC/DTC ID Global Market by Syndrome
  • Table 26 STD Testing market by country
  • Table 27 UTI Testing market by country
  • Table 28 HxV Testing market by country
  • Table 29 Other Testing market by country
  • Table 30 DTC Testing market by country
  • Table 31 HSG Testing market by country
  • Table 32 2019 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Medicare Clinical Lab Expenditures 2014 to 2024 ($Million)
  • Figure 2 HIV Virion
  • Figure 3 Diagram of the HIV Replication Cycle
  • Figure 4 The Structure of the HBV Virus
  • Figure 5 Hepatitis B Replication
  • Figure 6 Structure of the HCV Virus
  • Figure 7 HCV Replication Cycle
  • Figure 8 Structure of the Influenza Virion
  • Figure 9 Influenza Replication
  • Figure 10 Chart Death Rates and Infectious Disease Decline
  • Figure 11 The Multiplex Paradigm Shift
  • Figure 12 Market Size by Country - Key Countries
  • Figure 13 Chart of Global Market by Syndrome by Year
  • Figure 14 Syndrome Segment Shares 2019 vs 2014
  • Figure 15 Syndrome Share 2019
  • Figure 16 Syndrome Share 2024
  • Figure 17 Chart - Respiratory market 5 Year Growth
  • Figure 18 Chart - STD market 5 Year Growht
  • Figure 19 Chart - UTI 5 Year market Growth
  • Figure 20 Chart - HxV market 5 Year Growth
  • Figure 21 Chart - Other market 5 Year Growth
  • Figure 22 Channel Share by Year
  • Figure 23 Chart - OTC Channel 5 Year Growth
  • Figure 24 Chart - DTC Channel 5 Year Growth
  • Figure 25 Chart - HSG Channel 5 Year Growth
目次

OVERVIEW:

Over the Counter and Direct to Consumer change the clinical lab testing industry. Sampling technology plays a role.

Genetic DTC testing led the way. Now Infectious disease testing is moving directly to the consumer. New sampling technology, rapid and multiplex tests have changed the picture on how and where testing is done. This report explores the DTC outlook for different syndromes. Find out where the action is and the learn about the players.

Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication.

The report has hundreds of pages of information including a complete list of Current 2019 United States Medicare Fee Payment Schedules to help sharpen your pricing.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

  • iA. Situation Analysis
  • iB. Guide for Executives and Marketing Staff
  • iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

  • 1.1 What is OTC and DTC Testing?
  • 1.2 OTC/DTC Testing - the quiet revolution in diagnostics
  • 1.3 Self vs. Send - who knew?
  • 1.4 Market Definition
    • 1.4.1 Retail vs. Wholesale
    • 1.42 OTC, DTC, HxV and HSG
    • 1.4.3 Currency
    • 1.4.4 Years
  • 1.5 Methodology
    • 1.5.1 Authors
    • 1.5.2 Sources
  • 1.6 U.S. Medical Market and Clinical Laboratory Testing - Perspective
    • 1.6.1 U.S. Medicare Expenditures for Clinical Testing

2. The Infectious Diseases - Guide to the Pathogens

  • 2.1 HIV - Human Immunodeficiency Virus (AIDS)
    • 2.1.1 Virology
      • 2.1.1.1 Classification
      • 2.1.1.2 Structure and genome
      • 2.1.1.3 Tropism
      • 2.1.1.4 Replication cycle
      • 2.1.1.5 Genetic variability
    • 2.1.2 Diagnosis
    • 2.1.3 Testing
      • 2.1.3.1 Antibody tests
      • 2.1.3.2 Point of Care Tests (POCT)
      • 2.1.3.4 Antigen Tests
      • 2.1.3.5 Nucleic acid-based tests (NAT)
      • 2.1.3.6 Other tests used in HIV treatment
  • 2.2 HBV - Hepatitis B
    • 2.2.1 Virology
      • 2.2.1.1 Genome
      • 2.2.1.2 Pathogenesis
      • 2.2.1.3 Hepatitis B virus replication
      • 2.2.1.4 Serotypes and genotypes
    • 2.2.2 Mechanisms
    • 2.2.3 Diagnosis
    • 2.2.4 Market Opportunity Analysis
  • 2.3 HCV - Hepatitis C
    • 2.3.1 Taxonomy
      • 2.3.2.1 Structure
      • 2.3.2.2 Genome
    • 2.3.3 Molecular biology
    • 2.3.4 Replication
    • 2.3.5 Genotypes
      • 2.3.5.1 Clinical importance
    • 2.3.6 Market Opportunity Analysis
  • 2.4 HPV - Human papillomavirus
    • 2.4.1 Virology
      • 2.4.1.1 E6/E7 proteins
      • 2.4.1.2 Role in cancer
      • 2.4.1.3 E2 research
      • 2.4.1.4 Latency period
      • 2.4.1.5 Clearance
    • 2.4.2 Diagnosis
      • 2.4.2.1 Cervical testing
      • 2.4.2.2 Oral testing
      • 2.4.2.3 Testing men
      • 2.4.2.4 Other testing
    • 2.4.3 Market Opportunity Analysis
  • 2.5 Influenza
    • 2.5.1 Virology
      • 2.5.1.1 Types of virus
      • 2.5.1.2 Influenzavirus A
      • 2.5.1.3 Influenzavirus B
      • 2.5.1.4 Influenzavirus C
      • 2.5.1.5 Structure, properties, and subtype nomenclature
      • 2.5.1.6 Replication
    • 2.5.2 Testing
      • 2.5.2.1 Advantages/Disadvantages of Molecular Assays
    • 2.5.3 Market Opportunity Analysis
  • 2.6 CT/NG - Chlamydia/Gonorhea
    • 2.6.1 Gonorrhea
      • 2.6.1.1 Diagnosis
      • 2.6.1.2 Screening
    • 2.6.2 Chlamydia
      • 2.6.2.1 Diagnosis
      • 2.6.2.2 Screening
    • 2.6.3 Testing
      • 2.6.3.1 Nucleic acid amplification tests (NAATs).
      • 2.6.3.2 Performance of NAAT Tests
    • 2.6.4 Market Opportunity Analysis
  • 2.7 UTI
    • 2.7.1 Diagnosis
    • 2.7.2 Testing
      • 2.7.2.1 Nitrites test
      • 2.7.2.2 Leukocytes test
    • 2.7.3 Market Opportunity Analysis
  • 2.8 GAS
    • 2.8.1 Infectious Agents
    • 2.8.2 Market Opportunity Analysis
  • 2.9 RESP
    • 2.9.1 Diagnosis
    • 2.9.2 Market Opportunity Analysis

3. Industry Overview

  • 3.1 Industry Participants
    • 3.1.1 IVD Supplier
    • 3.1.2 Independent lab specialized/esoteric
    • 3.1.3 Independent lab national/regional
    • 3.1.4 Independent lab analytical
    • 3.1.5 Public National/regional lab
    • 3.1.6 Hospital lab
    • 3.1.7 Physician lab
    • 3.1.8 Pharmacies
    • 3.1.9 Audit body
  • 3.2 The Clinical Laboratory Market Segments
    • 3.2.1 Traditional Market Segmentation
    • 3.2.2 Laboratory Focus and Segmentation
    • 3.2.3 Segmenting the OTC/DTC Market
  • 3.3 Industry Structure
    • 3.3.1 Hospital Testing Share
    • 3.3.2 Economies of Scale
      • 3.3.2.1 Hospital vs. Central Lab
    • 3.3.3 Physician Office Lab's
      • 3.3.3.1 The Problem with POLS
    • 3.3.4 Physician's and OCT/DTC
    • 3.3.5 Pharmacies and OCT/DTC
      • 3.3.5.1 The Diagnostic Plight of Pharmacies - Trying to do good
      • 3.3.5.2 The Theranos Legacy

4. Market Trends

  • 4.1 Factors Driving Growth
    • 4.1.1 Privacy and Anonymity
    • 4.1.2 The Internet Effect.
    • 4.1.3 Rapid Result.
    • 4.1.4 The Wellness Movement
  • 4.2 Factors Limiting Growth
    • 4.2.1 Trust Factor
    • 4.2.2 Infectious Disease is Declining But....
    • 4.2.3 Wellness Hurts
    • 4.2.4 Economic Growth improves Living Standards
  • 4.3 Diagnostic Technology Development
    • 4.3.1 The Multiplex Paradigm Shift
    • 4.3.2 NAT vs. Lateral Flow
    • 4.3.3 The Unusual Role of GPS
    • 4.3.4 Self and Send Competition
    • 4.4.5 The Relationship to DTC Genetic
    • 4.4.6 The Relationship to TeleHealth
    • 4.4.7 Sample Collection - Who Knew?

5. OTC/DTC Infectious Disease Testing Recent Developments

  • Recent Developments - Importance and How to Use This Section
  • Importance of These Developments
  • How to Use This Section
  • Biohacking trend supports self testing.
  • PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market
  • Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test
  • Miraca Holdings Inc. and Seventh Sense Biosystems, Inc. Announce Distribution Agreement
  • OraSure Technologies, Inc. Announces Two Acquisitions
  • Mylan signs HIV test commercialisation deal with Atomo Diagnostics
  • Nigerian Govt Approves Alere HIV Self-Test Kit
  • Rapid HIV tests vary in their accuracy
  • Montreal researchers develop HIV self-testing app
  • Boots launches UTI test and treat service across 37 branches
  • Scanwell Health moves beyond home UTI testing with nationwide kidney disease study partnership
  • Healthy.io raises $18 million for at-home urinalysis tests
  • LetsGetChecked collects $30M more for at-home health testing
  • TestCard, a $4 Urine Test Read by Smartphone
  • Digital Health Startup EverlyWell Raises $50M
  • Thriva adds test-at-home kits for female hormone and cortisol stress
  • Tasso scores $6.1M for patch-based home blood testing
  • LabCorp to offer self-testing home kits
  • 1Drop Diagnostics draws $4.25M for portable blood diagnostic panel
  • DBS Systems HEMAXIS receives CE/IVD mark
  • myLAB Box Announces $1.56M in Seed Funding
  • Abbott HbA1c point-of-care test reliably diagnoses diabetes

6. Profiles of Key Diagnostic Testing Companies

  • 1DropDiagnostics
  • Abbott Diagnostics (Alere)
  • Atomo Diagnostics
  • Ador Diagnostics
  • Akkoni Biosystems
  • Alveo Technologies
  • Applied BioCode
  • Atlas Genetics
  • Aus Diagnostics
  • BD Diagnostics
  • Biocartis
  • BioFire Diagnostics
  • bioMérieux
  • Bio-Rad Laboratories
  • Bosch Healthcare Solutions GmbH
  • Cepheid
  • Curetis
  • DBS Systems
  • Diagenode Diagnostics
  • Diasorin
  • Everlywell
  • Fusion Genomics.
  • GenePOC Diagnostics
  • GenMark Dx
  • Healthy.IO
  • Hologic
  • Inflammatix
  • Inui Health
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Labcorp - Pixel
  • Letsgetchecked
  • Lexigene
  • Luminex
  • Mbio Diagnostics
  • Mesa Biotech
  • Mobidiag
  • myLabBox
  • Mylan
  • Nanomix
  • Orasure
  • Oxford Nanopore
  • Panagene
  • Primerdesign
  • Prominex
  • Qiagen (Statdx)
  • Quantumdx
  • Quest Diagnostics - Quest Direct
  • Roche Molecular Diagnostics
  • Scanwell Health
  • Seegene
  • Sensovation
  • Seventh Sense Biosystems
  • Siemens Healthineers (Fast Track Diagnostics)
  • SkylineDx
  • T2 Biosystems
  • TestCard Diagnostics
  • Thermo Fisher
  • Thriva
  • Veramarx
  • XCR Diagnostics

7. Global Market Size

  • 7.1 OTC/DTC ID Global Market Size by Country with Charts
  • 7.2 OTC/DTC ID Global Market Size by Syndrome with Charts

8. Global Market by Syndrome

  • 8.1 Respiratory Syndrome Market
    • 8.1.1 Respiratory Syndrome Market by Country
  • 8.2 STD Market
    • 8.2.1 STD Market by Country with Chart
  • 8.3 UTI Market
    • 8.3.1 UTI Market by Country with Chart
  • 8.4 HxV Market
    • 8.4.1 HxV Market by Country with Chart
  • 8.5 Other Market
    • 8.5.1 Other Market by Country with Chart

9. Global Market by Channel

  • 9.1 OTC/DTC Market by Channel
    • 9.1.1 OTC/DTC Market by Channel with Chart
  • 9.2 OTC Market
    • 9.2.1 OTC Market by Country
  • 9.3 DTC Market
    • 9.3.1 DTC Market by Country with Chart
  • 9.4 HSG Market
    • 9.4.1 HSG Market by Country with Chart

Appendices

  • I. United States Medicare System: 2019 Clinical Laboratory Fees Schedule
  • II. FDA Approved Microbial Tests
Back to Top